HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Digoxin for the treatment of chronic and acute heart failure syndromes.

Abstract
Digitalis preparations have been used for centuries. Digoxin is an agent that is readily available, can be administered acutely and long-term, intravenously or orally, is safe and may be beneficial in both acute and chronic heart failure (HF). It may be an ideal drug for the treatment of acute heart failure syndromes and warrants further investigation in large clinical trials. The role of digoxin in acute and chronic HF was discussed at the 2008 European Society of Cardiology Working Group on Acute Cardiac Care Meeting held in Versailles, France from 25-28 October 2008. This report represents a summary of the presentation at this meeting.
AuthorsMihai Gheorghiade, Matthew E Harinstein, Gerasimos S Filippatos
JournalAcute cardiac care (Acute Card Care) Vol. 11 Issue 2 Pg. 83-7 ( 2009) ISSN: 1748-2941 [Print] England
PMID19384675 (Publication Type: Journal Article, Review)
Chemical References
  • Cardiotonic Agents
  • Digoxin
Topics
  • Acute Disease
  • Cardiotonic Agents (therapeutic use)
  • Digoxin (therapeutic use)
  • Heart Failure (drug therapy, physiopathology)
  • Humans
  • Stroke Volume (drug effects)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: